Novel biphenyl derivatives of the general formula (I) in which R.sup.1, R.sup.1', R.sup.1'', R.sup.2, R.sup.2', R.sup.3 and n are as defined in claim 1, their stereoisomers and their physiologically acceptable salts or solvates are novel integrin inhibitors which preferentially inhibit the .alpha..sub.v.beta..sub.6 integrin receptor. The novel compounds can be used, in particular, as medicaments. ##STR00001##